7th Sept 2021
TIME (Montréal - EDT):
7:00am - 8:00am
TIME (Europe - CEST):
1:00pm - 2:00pm
Publishing during a crisis: ethics and lessons learnt from COVID-19
7th Sept 2021 - 7:00am - 8:00am (Montreal - EDT) |
1:00pm - 2:00pm (CEST)
Registrations Required - Click to Register!
The effects of COVID-19 continue to be felt around the world. For science and research, the pandemic has put unprecedented pressure on researchers and policy makers and is likely to influence the future of scientific research and scholarly communication. What have we learned from our experience so far? Are the mechanisms in place to validate research optimized and are we bridging the gap between science, policy and citizens in the most effective way?
This Elsevier-organized INGSA satellite session is focused on the communication implications of publishing during a crisis and the need for real time information to inform public policy decisions. This session will be a lively panel discussion on the emerging lessons learnt from the pandemic that will include:
- Pressures on the peer review system when faced with an unprecedented increase in submissions
- Mechanism of knowledge transfer to inform policy decisions in real time
- Burden on Editors to both identify key research in the fight against COVID 19 but to also act as guardians of quality
- Acceleration of open science and importance of reproducibility with the emerging need for data disclosure
- The role of publishers and science journalism in communicating research findings to citizens and increased blurred boundaries between preprints, accepted manuscripts, and peer reviewed articles
- How will the future look in a new era where computing power, money, and access to raw data govern independent validation?
The outcome of this discussion will help guide a pathway for science and research communication, providing input and consideration for publishers, science communication and policy advisors more broadly.
Professor Carlos Henrique de Brito Cruz
Senior Vice President, Elsevier Research Networks
Prof. Carlos Henrique de Brito Cruz sits on the Shell Science Council, the International Advisory Board of the Alexander von Humboldt Foundation, and the Panel of Judges for the Queen Elizabeth Engineering Prize. Prof. Brito Cruz is a member of the Brazilian Academy of Sciences (ABC) and a Fellow of the American Association for the Advancement of Science (AAAS).
He has authored and co-authored several scientific papers and in 2000 he was awarded the Order of Scientific Merit by the President of Brazil for his contributions to science and technology. In 2004 he also received the Conrado Wessel General Science Prize for his scientific career. He has also received the Ordre des Palmes Académiques de France, and the Order of the British Empire, Honorary (OBE) in 2015.
Mary Lowell Leary professor of medicine, Mayo Clinic in Rochester, Minnesota and Editor-in-Chief VACCINE
Gregory A. Poland, M.D., studies the immunogenetics of vaccine response in adults and children. Dr. Poland and his team within the Vaccine Research Group aim to improve the health of individuals across the world by pursuing challenges posed by infectious diseases and bioterrorism through clinical, laboratory and epidemiologic vaccine research. The Vaccine Research Group uses immunological testing, including serology, cell-mediated immunity, cell culture and cytokine assays; polymerase chain reaction (PCR) techniques and HLA typing for immunogenetic studies; and high-throughput assays, such as next-generation sequencing, transcriptomics, mass spectrometry and proteomic analysis. Dr. Poland's research has been continuously funded by the National Institutes of Health since 1991.
Katrina A Bramstedt
Chief Ethics Officer and Transplant Ethicist @Bond University School of Medicine, Australia
Ethical dilemmas arrive in all shapes and sizes, and can affect many domains: health/medicine, research, business, career, finance, and family. Ethicists work with clients to offer proactive steps to avoid ethical conflict, and also to solve active dilemmas. Beginning in 2002 and formerly on staff at The Cleveland Clinic, Professor Bramstedt has performed 1000+ consults across sport, biotech, pharma, medical device companies, patients, family members, medical teams, NGOs, IRBs/RECs, OPOs, the FDA, NIH, television producers, and attorneys. Additionally, she has authored 100+ articles in peer-reviewed medical and ethics journals, and lectured nationally and internationally. She has worked in inpatient and outpatient clinical settings, as well as industry (e.g., R&D, QA, Risk Management, Privacy, Compliance, Corporate Training) and has been active in medical student and doctoral education including curriculum development, teaching, and assessment, as well as research supervision, and misconduct and wellness. Currently, she is a Professor (adjunct) at Bond University School of Medicine
Global Education Editor @Financial Times
Andrew Jack has worked as a journalist for the Financial Times since 1990. He is currently the Global Education Editor, reporting and developing new projects including as editorial lead for free online FT access for schools. He previously ran the curated content team, picking the best news and analysis from the FT and the rest of the web, including FT Health. He was previously Deputy Editor of the Analysis section, Pharmaceuticals Correspondent, Moscow Bureau Chief, Paris Correspondent, Financial Correspondent, general reporter and corporate reporter. He is author of the books Inside Putin’s Russia and The French Exception, as well as numerous specialist reports, and has appeared on the BBC and other media outlets.